Definitive Healthcare faces structural revenue decline, weak retention, and competitive pressure, raising long-term concerns.

Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at UnitedHealth (NYSE:UNH) and its peers. Upfront premiums collected by ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

I got rid of times a stock gapped far above the prior close ... If/when these stocks make a new high, the analysis above shows call options have tended to give bullish results over the next ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.